Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Intrauterine Contraceptive Devices Market Size

ID: MRFR/HC/6977-HCR
200 Pages
Rahul Gotadki
December 2024

Intrauterine Contraceptive Devices (IUCDs) Market Research Report: Size, Share, Trend Analysis By Types (Copper Intrauterine Devices, Hormonal Intrauterine Devices, Multi-Load Intrauterine Devices), By Material (Copper, Plastic, Hormonal), By Distribution Channel (Hospitals, Gynecology Clinics, Pharmacies), By End Users (Women of Reproductive Age, Healthcare Providers, Family Planning Organizations) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Intrauterine Contraceptive Devices Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Intrauterine Contraceptive Devices Size

Intrauterine Contraceptive Devices Market Growth Projections and Opportunities

By 2032, the intrauterine contraceptive device (IUCD) market would reach USD 5.71 billion, rising 11.2% annually. The Intrauterine Contraceptive Device Marketing is affected by many factors. All of these factors form and build the industry. People are becoming more aware of and receptive to LARC choices, including IUCDs. IUCD sales have increased as more individuals seek simple, effective family planning methods. IUCDs function well, are simple to use, and last long, supporting this trend. These traits attract safe birth control seekers. Regulatory issues affect the IUCDs market because they ensure safe, effective, and proper usage. IUCDs must be authorized, manufactured, and distributed as prescribed. These standards promote safe business operations and user wellness. Following these criteria ensures IUCDs function and fosters confidence between healthcare staff and users. New contraceptive research and development technologies are transforming the IUCDs industry. IUCD design, materials, and injection processes are constantly updated to enhance user experience, reduce side effects, and increase choice. These technological developments aim to improve user experience, suit patient demands, and encourage more individuals to use IUCDs for birth control. Healthcare finances, long-term contraceptive cost-effectiveness, and inexpensive birth control impact IUCD adoption. IUCDs cost more upfront than some other birth control methods, but they're cheaper over time, offer more advantages, and don't need to be updated as frequently. This attracts healthcare personnel and long-term family planning users. Market dynamics and economic variables determine how simple it is to obtain new IUCD technology. There are several pharmaceutical and medical device businesses that develop various IUCDs, making this industry competitive. Due to competition, companies are developing IUCDs with superior design, less side effects, and personalized options to fit the demands of a broad spectrum of consumers. Healthcare providers may recommend IUCDs for each patient since there are so many alternatives. This helps the market adapt. Demographics including age, sexual desires, and long-term birth control impact market patterns. IUCDs are growing more popular as people realize how they may aid all ages, especially children. People also seek long-term family planning. Population changes alter the requirement for particular IUCDs, which affects product development. Different cultures' views on family planning, birth control, and reproductive health impact the IUCDs industry. Acceptance of long-term birth control, cultural family planning regulations, and knowledge of birth control choices might influence a patient's decision to choose IUCDs. Cultural influences affect healthcare staff' and patients' communication, which impacts IUCD usage choices. Different healthcare facilities, family planning programs, and cultural attitudes impact market considerations. Emerging and established countries may have varied IUCD and family planning information. These gaps are being reduced by improving healthcare systems, educating individuals about birth control options, and removing cultural obstacles. This impacts the worldwide IUCDs market.

Intrauterine Contraceptive Devices Market Size Graph
Author
Author Profile
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation for the Intrauterine Contraceptive Devices Market in 2035?

<p>The projected market valuation for the Intrauterine Contraceptive Devices Market in 2035 is 5497.87 USD Million.</p>

What was the market valuation for the Intrauterine Contraceptive Devices Market in 2024?

<p>The market valuation for the Intrauterine Contraceptive Devices Market in 2024 was 3370.0 USD Million.</p>

What is the expected CAGR for the Intrauterine Contraceptive Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Intrauterine Contraceptive Devices Market during the forecast period 2025 - 2035 is 4.55%.</p>

Which companies are considered key players in the Intrauterine Contraceptive Devices Market?

<p>Key players in the Intrauterine Contraceptive Devices Market include Bayer AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., and others.</p>

What are the market segments for Intrauterine Contraceptive Devices by product type?

<p>The market segments by product type include Copper Intrauterine Devices, Hormonal Intrauterine Devices, and Non-Hormonal Intrauterine Devices.</p>

What was the valuation for Hormonal Intrauterine Devices in 2024?

<p>The valuation for Hormonal Intrauterine Devices in 2024 was 1500.0 USD Million.</p>

How do the valuations for Copper and Plastic Intrauterine Devices compare in 2024?

<p>In 2024, the valuation for Copper Intrauterine Devices was 1000.0 USD Million, while Plastic Intrauterine Devices also reached 1000.0 USD Million.</p>

What is the projected valuation for the Home Care segment by 2035?

<p>The projected valuation for the Home Care segment by 2035 is expected to reach 1247.87 USD Million.</p>

What are the age group segments for the Intrauterine Contraceptive Devices Market?

<p>The age group segments include Adolescents, Adults, and Women of Reproductive Age.</p>

What was the valuation for the Adults age group segment in 2024?

<p>The valuation for the Adults age group segment in 2024 was 1200.0 USD Million.</p>

Market Summary

As per MRFR analysis, the Intrauterine Contraceptive Devices Market Size was estimated at 3370.0 USD Million in 2024. The Intrauterine Contraceptive Devices industry is projected to grow from 3523.34 USD Million in 2025 to 5497.87 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.55% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Intrauterine Contraceptive Devices Market is experiencing robust growth driven by technological advancements and increasing awareness of reproductive health.

  • North America remains the largest market for intrauterine contraceptive devices, reflecting a strong demand for effective family planning solutions. The Asia-Pacific region is identified as the fastest-growing market, driven by rising awareness and accessibility of reproductive health services. Technological innovations in device design are enhancing user experience and efficacy, appealing to a broader demographic. The increasing demand for long-acting reversible contraceptives and government initiatives supporting family planning are key drivers of market growth.

Market Size & Forecast

2024 Market Size 3370.0 (USD Million)
2035 Market Size 5497.87 (USD Million)
CAGR (2025 - 2035) 4.55%
Largest Regional Market Share in 2024 North America

Major Players

Bayer AG (DE), Merck &amp; Co., Inc. (US), Teva Pharmaceutical Industries Ltd. (IL), CooperSurgical, Inc. (US), Hologic, Inc. (US), Mylan N.V. (US), Smith &amp; Nephew plc (GB), Daiichi Sankyo Company, Limited (JP)

Market Trends

The Intrauterine Contraceptive Devices Market is currently experiencing a notable transformation, driven by evolving consumer preferences and advancements in medical technology. As awareness regarding reproductive health increases, more individuals are seeking effective and long-term contraceptive solutions. This shift is likely to enhance the demand for intrauterine devices, which are recognized for their efficacy and convenience. Furthermore, the growing emphasis on family planning and population control initiatives across various regions appears to be contributing to the market's expansion. Healthcare providers are increasingly recommending these devices due to their safety profile and minimal side effects, which may further bolster their adoption. In addition, the Intrauterine Contraceptive Devices Market is witnessing innovations in product design and materials, which could lead to improved user experiences. Manufacturers are focusing on developing devices that are not only more comfortable but also easier to insert and remove. This trend suggests a potential increase in user satisfaction and adherence to contraceptive methods. Moreover, the integration of digital health technologies into reproductive health services may enhance access to information and support for users, thereby promoting the use of intrauterine devices. Overall, the market appears poised for growth as it adapts to the changing landscape of reproductive health needs and preferences.

Rising Awareness of Reproductive Health

There is a growing recognition of the importance of reproductive health, leading to increased interest in effective contraceptive methods. This trend is likely to drive more individuals towards intrauterine devices as a reliable option.

Technological Advancements in Device Design

Innovations in the design and materials of intrauterine devices are emerging, potentially enhancing user comfort and ease of use. These advancements may contribute to higher satisfaction rates among users.

Integration of Digital Health Solutions

The incorporation of digital health technologies into reproductive health services is becoming more prevalent. This trend could facilitate better access to information and support for individuals considering intrauterine contraceptive options.

Intrauterine Contraceptive Devices Market Market Drivers

Rising Focus on Family Planning

The Intrauterine Contraceptive Devices Market is significantly influenced by the rising focus on family planning across various demographics. As societies evolve, there is an increasing recognition of the importance of family planning in achieving personal and economic goals. This shift is reflected in the growing number of women seeking effective contraceptive methods, such as IUDs, to manage their reproductive health. Data indicates that regions with robust family planning initiatives have seen a marked increase in the uptake of IUDs. Consequently, the Intrauterine Contraceptive Devices Market is poised for growth as more individuals prioritize family planning and seek reliable contraceptive solutions.

Government Initiatives and Support

Government initiatives aimed at promoting reproductive health are playing a crucial role in the Intrauterine Contraceptive Devices Market. Many countries are implementing policies that encourage the use of contraceptives, including IUDs, as part of broader public health strategies. These initiatives often include funding for family planning programs, educational campaigns, and subsidized access to contraceptive methods. For instance, some governments have allocated substantial budgets to improve access to reproductive health services, which has led to increased availability of IUDs. This support not only enhances awareness but also fosters a favorable environment for the growth of the Intrauterine Contraceptive Devices Market, as more women gain access to these essential health services.

Technological Innovations in IUD Design

Technological innovations in the design and functionality of intrauterine devices are transforming the Intrauterine Contraceptive Devices Market. Advances in materials and manufacturing processes have led to the development of more effective and user-friendly IUDs. For instance, newer models are designed to minimize discomfort during insertion and enhance overall user experience. Additionally, innovations such as hormone-releasing IUDs have expanded the options available to women, catering to diverse needs and preferences. As these technological advancements continue to emerge, they are expected to drive the growth of the Intrauterine Contraceptive Devices Market, attracting more users seeking modern and effective contraceptive solutions.

Enhanced Education and Awareness Campaigns

Education and awareness campaigns regarding reproductive health are pivotal in shaping the Intrauterine Contraceptive Devices Market. These campaigns aim to inform women about the various contraceptive options available, including the benefits and risks associated with IUDs. Increased knowledge empowers women to make informed choices about their reproductive health. Recent statistics suggest that regions with comprehensive educational programs have experienced a rise in IUD usage, indicating a direct correlation between awareness and adoption rates. As more organizations and healthcare providers invest in these initiatives, the Intrauterine Contraceptive Devices Market is likely to witness sustained growth, driven by an informed consumer base.

Increasing Demand for Long-Acting Reversible Contraceptives

The Intrauterine Contraceptive Devices Market is experiencing a notable surge in demand for long-acting reversible contraceptives (LARCs). This trend is largely attributed to the growing awareness among women regarding the benefits of LARCs, which include reduced need for frequent medical visits and high efficacy rates. According to recent data, LARCs, including intrauterine devices (IUDs), account for a significant portion of contraceptive use in various regions. The convenience and effectiveness of IUDs are appealing to many women, leading to an increase in their adoption. As more healthcare providers advocate for LARCs, the Intrauterine Contraceptive Devices Market is likely to expand further, catering to the evolving preferences of women seeking reliable contraceptive options.

Market Segment Insights

By Product Type: Copper Intrauterine Device (Largest) vs. Hormonal Intrauterine Device (Fastest-Growing)

<p>The Intrauterine Contraceptive Devices Market showcases diverse segments, with the Copper Intrauterine Device (IUD) holding the largest market share due to its long-term efficacy and widespread acceptance among users. The effectiveness of Copper IUDs in preventing pregnancy for up to ten years and the absence of hormones make them a preferred option among many women, especially in regions where hormonal contraceptives may not be favored. In contrast, Hormonal IUDs are rapidly gaining traction, appealing to those seeking additional benefits such as reduced menstrual bleeding and other health advantages. These devices are increasingly being recommended by healthcare professionals, further boosting their adoption.</p>

<p>Copper IUD (Dominant) vs. Hormonal IUD (Emerging)</p>

<p>The Copper IUD stands out as a dominant player in the intrauterine contraceptive market. It offers a highly effective, non-hormonal method of contraception that can be used for several years, making it a go-to choice for women looking for long-term solutions. Its popularity is attributed to its safety, ease of use, and minimal side effects, which cater to diverse populations, particularly in regions averse to hormonal methods. Conversely, the Hormonal IUD is emerging strongly, particularly among women seeking additional menstrual health benefits. This device releases hormones that not only prevent pregnancy but also can alleviate menstrual cramps and heavy bleeding, ideal for women with specific health concerns. As awareness and acceptance grow, this segment's market share is expected to expand significantly, appealing to younger demographics and women prioritizing convenience.</p>

By Material Type: Plastic (Largest) vs. Copper (Fastest-Growing)

<p>The Intrauterine Contraceptive Devices Market is primarily segmented by material type, with plastic devices currently holding the largest market share due to their widespread acceptance and availability. Plastic IUDs are favored for their ease of use, stability, and low manufacturing costs, thus making them a preferred choice among healthcare providers and patients alike. In contrast, copper IUDs have gained significant traction, recognized for their effectiveness without hormones, and are rapidly becoming popular in many regions.</p>

<p>Material Type: Plastic (Dominant) vs. Copper (Emerging)</p>

<p>Plastic IUDs are currently the dominant material segment, characterized by their long shelf life, flexibility, and patient comfort. They have established a strong foothold in developed markets where demand for non-hormonal contraceptive options is rising. On the other hand, copper IUDs, while emerging, have demonstrated remarkable growth due to their non-hormonal nature and added efficacy in preventing pregnancies. This has been endorsed by a rise in awareness and acceptance of long-term contraceptive options, highlighting a promising future for copper devices in the market.</p>

By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

<p>The Intrauterine Contraceptive Devices Market shows a significant distribution among end users, with hospitals holding the largest market share. Hospitals benefit from advanced facilities and a high volume of patients, making them a primary choice for intrauterine device (IUD) procedures. On the other hand, clinics are rapidly gaining traction, especially with the growing emphasis on accessible reproductive health services. This shift is fostering a competitive landscape as clinics become key players in providing IUDs, focusing on personalized care and advice to patients seeking contraceptive options. Growth trends in the Intrauterine Contraceptive Devices Market are influenced by factors such as increasing awareness of reproductive health and the growing preference for long-acting reversible contraceptives. As more individuals seek effective and convenient contraceptive methods, clinics have emerged as ideal providers, often offering services that cater to specific patient needs. Additionally, the expansion of healthcare policies promoting family planning is driving market growth, enhancing the roles of both hospitals and clinics in delivering crucial reproductive health services.</p>

<p>Hospitals (Dominant) vs. Clinics (Emerging)</p>

<p>Hospitals represent the dominant end user segment in the Intrauterine Contraceptive Devices Market due to their comprehensive healthcare capabilities, extensive resources, and the ability to handle complex cases. They typically offer a full range of reproductive health services, which positions them as trusted sources for IUD placements and education. Hospitals also tend to have established relationships with patients, resulting in higher rates of IUD acceptance during consultations. Conversely, clinics are emerging as vital providers of intrauterine devices, capitalizing on trends towards more accessible reproductive healthcare. Their focus on delivering personalized services and shorter wait times appeals to many individuals, particularly those who prefer a less formal setting. This evolution reflects a shift towards more patient-centric care pathways, allowing clinics to cater to a diverse demographic seeking long-term contraceptive solutions.</p>

By Duration of Use: Long-term (Largest) vs. Short-term (Fastest-Growing)

<p>In the Intrauterine Contraceptive Devices (IUD) market, the segment for Long-term use has established itself as the largest distribution channel, largely due to its growing acceptance for extended contraceptive efficacy. This value is complemented by an increasing number of women opting for IUDs that provide up to ten years of protection. Meanwhile, the Short-term use segment, while smaller in market share, is rapidly gaining traction among younger demographics who prefer flexibility in their contraceptive choices and are more informed about various options available to them.</p>

<p>Duration of Use: Long-term (Dominant) vs. Short-term (Emerging)</p>

<p>The Long-term segment of intrauterine contraceptive devices is characterized by its stability and reliability. Women opting for this choice are assured of a prolonged contraceptive effect, aligning with family planning needs that require minimal maintenance. These devices typically appeal to those seeking to avoid the routine of other forms of birth control. On the other hand, the Short-term segment is emerging rapidly, particularly among younger women. This demographic values the choice of temporary solutions that fit into their individual lifestyles without long-term commitment. Factors such as educational outreach regarding sexual health and healthcare provider recommendations are driving the growth in this segment, as more women look for safe and reversible options.</p>

By Age Group: Women of Reproductive Age (Largest) vs. Adolescents (Fastest-Growing)

In the Intrauterine Contraceptive Devices Market, the distribution of market share among the age groups reveals that women of reproductive age represent the largest segment, notably due to their heightened need for effective long-term contraceptive methods. This demographic’s awareness of intrauterine devices is also significantly higher, resulting in broader acceptance and usage rates compared to adolescents and adults. The adult segment commands a fair share, but it is climbing steadily, particularly as educational campaigns increase throughout various regions. As the market progresses, adolescents are emerging as the fastest-growing segment in the intrauterine contraceptive devices sector. This shift can be attributed to the rising trend of exploring long-term contraceptive options among younger people, coupled with increased access to reproductive healthcare services. The growing advocacy for sexual health education and awareness has contributed to adolescents' willingness to consider and adopt these devices, further expanding the market's reach in this demographic.

Women of Reproductive Age (Dominant) vs. Adolescents (Emerging)

The dominant segment, women of reproductive age, is characterized by its significant demand for intrauterine contraceptive devices, driven by the desire for effective and long-term birth control solutions. This demographic has been influenced by various factors including changing social norms, increasing education levels, and a focus on women's health, leading to a higher adoption rate of these devices. In contrast, the emerging segment of adolescents showcases a growing openness to long-term contraceptive options, energized by educational initiatives and guidance from healthcare providers. As adolescents continue to prioritize their reproductive health and seek alternatives to traditional methods, the intrauterine contraceptive device market is positioned to evolve rapidly within this age group, creating new opportunities for growth.

Get more detailed insights about Intrauterine Contraceptive Devices Market Research Report-Forecast to 2035

Regional Insights

North America : Market Leader in Contraceptives

North America is poised to maintain its leadership in the Intrauterine Contraceptive Devices market, holding a significant market share of $1685.0M in 2024. The growth is driven by increasing awareness of reproductive health, favorable reimbursement policies, and a rising trend towards long-acting reversible contraceptives (LARCs). Regulatory support from health authorities further catalyzes market expansion, ensuring accessibility and safety for users. The United States and Canada are the leading countries in this region, with major players like Bayer AG, Merck & Co., and CooperSurgical, Inc. dominating the landscape. The competitive environment is characterized by continuous innovation and strategic partnerships among key players, enhancing product offerings and market penetration. The presence of advanced healthcare infrastructure also supports the adoption of intrauterine devices, contributing to the region's robust market performance.

Europe : Growing Demand for Contraceptive Options

Europe's Intrauterine Contraceptive Devices market is projected to reach $1005.0M by 2024, driven by increasing demand for effective contraceptive methods and a growing focus on women's health. Regulatory frameworks across various countries are evolving to support the use of LARCs, which are gaining popularity due to their long-term efficacy and convenience. Initiatives by health organizations to promote family planning further bolster market growth. Leading countries in this region include Germany, France, and the UK, where key players like Merck & Co. and Hologic, Inc. are actively engaged. The competitive landscape is marked by innovation and a diverse range of products catering to different consumer needs. The presence of strong distribution networks and healthcare providers enhances accessibility, making intrauterine devices a preferred choice among women in Europe.

Asia-Pacific : Emerging Market with Potential

The Asia-Pacific region is witnessing a growing interest in Intrauterine Contraceptive Devices, with a market size of $550.0M in 2024. Factors such as increasing awareness of reproductive health, government initiatives promoting family planning, and a shift towards modern contraceptive methods are driving this growth. Regulatory bodies are also playing a crucial role in ensuring the safety and efficacy of these devices, which is vital for consumer confidence. Countries like India, China, and Japan are at the forefront of this market, with key players such as Teva Pharmaceutical Industries and Daiichi Sankyo Company actively participating. The competitive landscape is evolving, with local manufacturers emerging alongside established global brands. This dynamic environment is fostering innovation and expanding the availability of intrauterine devices, catering to the diverse needs of women across the region.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region represents an untapped market for Intrauterine Contraceptive Devices, with a market size of $130.0M in 2024. The growth potential is driven by increasing awareness of family planning and reproductive health, alongside supportive government policies aimed at improving women's health services. However, cultural factors and limited access to healthcare can pose challenges to market penetration. Countries such as South Africa and Egypt are leading the way in adopting modern contraceptive methods, with key players like Mylan N.V. and Smith & Nephew plc making strides in the region. The competitive landscape is gradually evolving, with a focus on education and outreach programs to promote the benefits of intrauterine devices. This presents significant opportunities for growth as awareness and acceptance continue to rise.

Key Players and Competitive Insights

The Intrauterine Contraceptive Devices Market is characterized by a dynamic competitive landscape, driven by increasing awareness of reproductive health and a growing preference for long-term contraceptive solutions. Key players such as Bayer AG (DE), Merck & Co., Inc. (US), and CooperSurgical, Inc. (US) are strategically positioned to leverage innovation and regional expansion to enhance their market presence. Bayer AG (DE) focuses on product innovation, particularly in developing next-generation intrauterine devices (IUDs) that cater to diverse consumer needs. Meanwhile, Merck & Co., Inc. (US) emphasizes partnerships with healthcare providers to improve access and education regarding contraceptive options, thereby fostering a more informed consumer base. CooperSurgical, Inc. (US) is actively pursuing mergers and acquisitions to broaden its product portfolio and strengthen its market foothold, indicating a trend towards consolidation in the sector.
The competitive structure of the market appears moderately fragmented, with several players vying for market share. Companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. This approach not only improves responsiveness to market demands but also aligns with sustainability goals, as firms seek to minimize their environmental impact. The collective influence of these key players shapes a competitive environment where innovation and operational efficiency are paramount.
In January 2026, Bayer AG (DE) announced the launch of a new IUD designed with advanced materials that enhance user comfort and efficacy. This strategic move is likely to position Bayer as a leader in product innovation, potentially attracting a broader consumer base seeking reliable contraceptive options. The introduction of this product may also stimulate competition, prompting other companies to accelerate their own R&D efforts.
In December 2025, Merck & Co., Inc. (US) entered into a strategic partnership with a leading telehealth provider to facilitate remote consultations for contraceptive counseling. This initiative underscores the growing trend of digital health solutions in reproductive care, allowing Merck to reach a wider audience and improve service delivery. Such partnerships may redefine how contraceptive options are presented to consumers, enhancing accessibility and education.
In November 2025, CooperSurgical, Inc. (US) completed the acquisition of a smaller firm specializing in innovative contraceptive technologies. This acquisition is indicative of a broader trend towards consolidation in the market, as companies seek to enhance their product offerings and leverage synergies. By integrating new technologies, CooperSurgical may strengthen its competitive position and expand its market reach.
As of February 2026, current trends in the Intrauterine Contraceptive Devices Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and improving service delivery. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, product innovation, and supply chain reliability. This shift may ultimately lead to a more sustainable and consumer-centric market landscape.

Key Companies in the Intrauterine Contraceptive Devices Market include

Industry Developments

Recent developments in the Intrauterine Contraceptive Devices Market (IUCDs) Market have shown a continued emphasis on innovation and market expansion, particularly through advancements in product design and materials. Notable growth trends have emerged, with an increased focus on creating more comfortable and effective IUCD options, catering to a diverse range of patient needs across various demographics.

  • In February 2025, MIUDELLA, a low-dose copper IUD that is the next generation, was approved by the FDA by Sebela Pharmaceuticals. This device allows for pregnancy prevention for a period of up to three years.
  • In September 2024, CooperSurgical introduced a new single-hand inserter for Paragard® copper IUD, which the U.S. Food and Drug Administration approved.
  • In April 2024, ASPIVIX (a women's health medtech company) collaborated with Bayer Switzerland to introduce Carevix, a cervical stabilizer that improves comfort during IUD insertions.

Future Outlook

Intrauterine Contraceptive Devices Market Future Outlook

The Intrauterine Contraceptive Devices Market is projected to grow at a 4.55% CAGR from 2024 to 2035, driven by increasing awareness and demand for long-term contraceptive solutions.

New opportunities lie in:

  • <p>Expansion into emerging markets with tailored educational campaigns Development of innovative, user-friendly device designs Partnerships with healthcare providers for integrated service offerings</p>

By 2035, the market is expected to solidify its position as a leading contraceptive solution.

Market Segmentation

Intrauterine Contraceptive Devices Market End User Outlook

  • Hospitals
  • Clinics
  • Home Care

Intrauterine Contraceptive Devices Market Age Group Outlook

  • Adolescents
  • Adults
  • Women of Reproductive Age

Intrauterine Contraceptive Devices Market Product Type Outlook

  • Copper Intrauterine Device
  • Hormonal Intrauterine Device
  • Non-Hormonal Intrauterine Device

Intrauterine Contraceptive Devices Market Material Type Outlook

  • Plastic
  • Copper
  • Silicone
  • Steel

Intrauterine Contraceptive Devices Market Duration of Use Outlook

  • Short-term
  • Long-term

Report Scope

MARKET SIZE 2024 3370.0(USD Million)
MARKET SIZE 2025 3523.34(USD Million)
MARKET SIZE 2035 5497.87(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.55% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Bayer AG (DE), Merck & Co., Inc. (US), Teva Pharmaceutical Industries Ltd. (IL), CooperSurgical, Inc. (US), Hologic, Inc. (US), Mylan N.V. (US), Smith & Nephew plc (GB), Daiichi Sankyo Company, Limited (JP)
Segments Covered Product Type, Material Type, End User, Duration of Use, Age Group
Key Market Opportunities Emergence of advanced biocompatible materials enhances safety and efficacy in the Intrauterine Contraceptive Devices Market.
Key Market Dynamics Rising consumer preference for long-term contraceptive solutions drives innovation and competition in the Intrauterine Contraceptive Devices market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation for the Intrauterine Contraceptive Devices Market in 2035?

<p>The projected market valuation for the Intrauterine Contraceptive Devices Market in 2035 is 5497.87 USD Million.</p>

What was the market valuation for the Intrauterine Contraceptive Devices Market in 2024?

<p>The market valuation for the Intrauterine Contraceptive Devices Market in 2024 was 3370.0 USD Million.</p>

What is the expected CAGR for the Intrauterine Contraceptive Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Intrauterine Contraceptive Devices Market during the forecast period 2025 - 2035 is 4.55%.</p>

Which companies are considered key players in the Intrauterine Contraceptive Devices Market?

<p>Key players in the Intrauterine Contraceptive Devices Market include Bayer AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., and others.</p>

What are the market segments for Intrauterine Contraceptive Devices by product type?

<p>The market segments by product type include Copper Intrauterine Devices, Hormonal Intrauterine Devices, and Non-Hormonal Intrauterine Devices.</p>

What was the valuation for Hormonal Intrauterine Devices in 2024?

<p>The valuation for Hormonal Intrauterine Devices in 2024 was 1500.0 USD Million.</p>

How do the valuations for Copper and Plastic Intrauterine Devices compare in 2024?

<p>In 2024, the valuation for Copper Intrauterine Devices was 1000.0 USD Million, while Plastic Intrauterine Devices also reached 1000.0 USD Million.</p>

What is the projected valuation for the Home Care segment by 2035?

<p>The projected valuation for the Home Care segment by 2035 is expected to reach 1247.87 USD Million.</p>

What are the age group segments for the Intrauterine Contraceptive Devices Market?

<p>The age group segments include Adolescents, Adults, and Women of Reproductive Age.</p>

What was the valuation for the Adults age group segment in 2024?

<p>The valuation for the Adults age group segment in 2024 was 1200.0 USD Million.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Product Type (USD Million)
    2. | | 4.1.1 Copper Intrauterine Device
    3. | | 4.1.2 Hormonal Intrauterine Device
    4. | | 4.1.3 Non-Hormonal Intrauterine Device
    5. | 4.2 Healthcare, BY Material Type (USD Million)
    6. | | 4.2.1 Plastic
    7. | | 4.2.2 Copper
    8. | | 4.2.3 Silicone
    9. | | 4.2.4 Steel
    10. | 4.3 Healthcare, BY End User (USD Million)
    11. | | 4.3.1 Hospitals
    12. | | 4.3.2 Clinics
    13. | | 4.3.3 Home Care
    14. | 4.4 Healthcare, BY Duration of Use (USD Million)
    15. | | 4.4.1 Short-term
    16. | | 4.4.2 Long-term
    17. | 4.5 Healthcare, BY Age Group (USD Million)
    18. | | 4.5.1 Adolescents
    19. | | 4.5.2 Adults
    20. | | 4.5.3 Women of Reproductive Age
    21. | 4.6 Healthcare, BY Region (USD Million)
    22. | | 4.6.1 North America
    23. | | | 4.6.1.1 US
    24. | | | 4.6.1.2 Canada
    25. | | 4.6.2 Europe
    26. | | | 4.6.2.1 Germany
    27. | | | 4.6.2.2 UK
    28. | | | 4.6.2.3 France
    29. | | | 4.6.2.4 Russia
    30. | | | 4.6.2.5 Italy
    31. | | | 4.6.2.6 Spain
    32. | | | 4.6.2.7 Rest of Europe
    33. | | 4.6.3 APAC
    34. | | | 4.6.3.1 China
    35. | | | 4.6.3.2 India
    36. | | | 4.6.3.3 Japan
    37. | | | 4.6.3.4 South Korea
    38. | | | 4.6.3.5 Malaysia
    39. | | | 4.6.3.6 Thailand
    40. | | | 4.6.3.7 Indonesia
    41. | | | 4.6.3.8 Rest of APAC
    42. | | 4.6.4 South America
    43. | | | 4.6.4.1 Brazil
    44. | | | 4.6.4.2 Mexico
    45. | | | 4.6.4.3 Argentina
    46. | | | 4.6.4.4 Rest of South America
    47. | | 4.6.5 MEA
    48. | | | 4.6.5.1 GCC Countries
    49. | | | 4.6.5.2 South Africa
    50. | | | 4.6.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Bayer AG (DE)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Merck & Co., Inc. (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Teva Pharmaceutical Industries Ltd. (IL)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 CooperSurgical, Inc. (US)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Hologic, Inc. (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Mylan N.V. (US)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Smith & Nephew plc (GB)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Daiichi Sankyo Company, Limited (JP)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | 5.3 Appendix
    65. | | 5.3.1 References
    66. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
    4. | 6.4 US MARKET ANALYSIS BY MATERIAL TYPE
    5. | 6.5 US MARKET ANALYSIS BY END USER
    6. | 6.6 US MARKET ANALYSIS BY DURATION OF USE
    7. | 6.7 US MARKET ANALYSIS BY AGE GROUP
    8. | 6.8 CANADA MARKET ANALYSIS BY PRODUCT TYPE
    9. | 6.9 CANADA MARKET ANALYSIS BY MATERIAL TYPE
    10. | 6.10 CANADA MARKET ANALYSIS BY END USER
    11. | 6.11 CANADA MARKET ANALYSIS BY DURATION OF USE
    12. | 6.12 CANADA MARKET ANALYSIS BY AGE GROUP
    13. | 6.13 EUROPE MARKET ANALYSIS
    14. | 6.14 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    15. | 6.15 GERMANY MARKET ANALYSIS BY MATERIAL TYPE
    16. | 6.16 GERMANY MARKET ANALYSIS BY END USER
    17. | 6.17 GERMANY MARKET ANALYSIS BY DURATION OF USE
    18. | 6.18 GERMANY MARKET ANALYSIS BY AGE GROUP
    19. | 6.19 UK MARKET ANALYSIS BY PRODUCT TYPE
    20. | 6.20 UK MARKET ANALYSIS BY MATERIAL TYPE
    21. | 6.21 UK MARKET ANALYSIS BY END USER
    22. | 6.22 UK MARKET ANALYSIS BY DURATION OF USE
    23. | 6.23 UK MARKET ANALYSIS BY AGE GROUP
    24. | 6.24 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    25. | 6.25 FRANCE MARKET ANALYSIS BY MATERIAL TYPE
    26. | 6.26 FRANCE MARKET ANALYSIS BY END USER
    27. | 6.27 FRANCE MARKET ANALYSIS BY DURATION OF USE
    28. | 6.28 FRANCE MARKET ANALYSIS BY AGE GROUP
    29. | 6.29 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    30. | 6.30 RUSSIA MARKET ANALYSIS BY MATERIAL TYPE
    31. | 6.31 RUSSIA MARKET ANALYSIS BY END USER
    32. | 6.32 RUSSIA MARKET ANALYSIS BY DURATION OF USE
    33. | 6.33 RUSSIA MARKET ANALYSIS BY AGE GROUP
    34. | 6.34 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    35. | 6.35 ITALY MARKET ANALYSIS BY MATERIAL TYPE
    36. | 6.36 ITALY MARKET ANALYSIS BY END USER
    37. | 6.37 ITALY MARKET ANALYSIS BY DURATION OF USE
    38. | 6.38 ITALY MARKET ANALYSIS BY AGE GROUP
    39. | 6.39 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    40. | 6.40 SPAIN MARKET ANALYSIS BY MATERIAL TYPE
    41. | 6.41 SPAIN MARKET ANALYSIS BY END USER
    42. | 6.42 SPAIN MARKET ANALYSIS BY DURATION OF USE
    43. | 6.43 SPAIN MARKET ANALYSIS BY AGE GROUP
    44. | 6.44 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    45. | 6.45 REST OF EUROPE MARKET ANALYSIS BY MATERIAL TYPE
    46. | 6.46 REST OF EUROPE MARKET ANALYSIS BY END USER
    47. | 6.47 REST OF EUROPE MARKET ANALYSIS BY DURATION OF USE
    48. | 6.48 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP
    49. | 6.49 APAC MARKET ANALYSIS
    50. | 6.50 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    51. | 6.51 CHINA MARKET ANALYSIS BY MATERIAL TYPE
    52. | 6.52 CHINA MARKET ANALYSIS BY END USER
    53. | 6.53 CHINA MARKET ANALYSIS BY DURATION OF USE
    54. | 6.54 CHINA MARKET ANALYSIS BY AGE GROUP
    55. | 6.55 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    56. | 6.56 INDIA MARKET ANALYSIS BY MATERIAL TYPE
    57. | 6.57 INDIA MARKET ANALYSIS BY END USER
    58. | 6.58 INDIA MARKET ANALYSIS BY DURATION OF USE
    59. | 6.59 INDIA MARKET ANALYSIS BY AGE GROUP
    60. | 6.60 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    61. | 6.61 JAPAN MARKET ANALYSIS BY MATERIAL TYPE
    62. | 6.62 JAPAN MARKET ANALYSIS BY END USER
    63. | 6.63 JAPAN MARKET ANALYSIS BY DURATION OF USE
    64. | 6.64 JAPAN MARKET ANALYSIS BY AGE GROUP
    65. | 6.65 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    66. | 6.66 SOUTH KOREA MARKET ANALYSIS BY MATERIAL TYPE
    67. | 6.67 SOUTH KOREA MARKET ANALYSIS BY END USER
    68. | 6.68 SOUTH KOREA MARKET ANALYSIS BY DURATION OF USE
    69. | 6.69 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP
    70. | 6.70 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    71. | 6.71 MALAYSIA MARKET ANALYSIS BY MATERIAL TYPE
    72. | 6.72 MALAYSIA MARKET ANALYSIS BY END USER
    73. | 6.73 MALAYSIA MARKET ANALYSIS BY DURATION OF USE
    74. | 6.74 MALAYSIA MARKET ANALYSIS BY AGE GROUP
    75. | 6.75 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    76. | 6.76 THAILAND MARKET ANALYSIS BY MATERIAL TYPE
    77. | 6.77 THAILAND MARKET ANALYSIS BY END USER
    78. | 6.78 THAILAND MARKET ANALYSIS BY DURATION OF USE
    79. | 6.79 THAILAND MARKET ANALYSIS BY AGE GROUP
    80. | 6.80 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    81. | 6.81 INDONESIA MARKET ANALYSIS BY MATERIAL TYPE
    82. | 6.82 INDONESIA MARKET ANALYSIS BY END USER
    83. | 6.83 INDONESIA MARKET ANALYSIS BY DURATION OF USE
    84. | 6.84 INDONESIA MARKET ANALYSIS BY AGE GROUP
    85. | 6.85 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    86. | 6.86 REST OF APAC MARKET ANALYSIS BY MATERIAL TYPE
    87. | 6.87 REST OF APAC MARKET ANALYSIS BY END USER
    88. | 6.88 REST OF APAC MARKET ANALYSIS BY DURATION OF USE
    89. | 6.89 REST OF APAC MARKET ANALYSIS BY AGE GROUP
    90. | 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. | 6.91 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    92. | 6.92 BRAZIL MARKET ANALYSIS BY MATERIAL TYPE
    93. | 6.93 BRAZIL MARKET ANALYSIS BY END USER
    94. | 6.94 BRAZIL MARKET ANALYSIS BY DURATION OF USE
    95. | 6.95 BRAZIL MARKET ANALYSIS BY AGE GROUP
    96. | 6.96 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    97. | 6.97 MEXICO MARKET ANALYSIS BY MATERIAL TYPE
    98. | 6.98 MEXICO MARKET ANALYSIS BY END USER
    99. | 6.99 MEXICO MARKET ANALYSIS BY DURATION OF USE
    100. | 6.100 MEXICO MARKET ANALYSIS BY AGE GROUP
    101. | 6.101 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    102. | 6.102 ARGENTINA MARKET ANALYSIS BY MATERIAL TYPE
    103. | 6.103 ARGENTINA MARKET ANALYSIS BY END USER
    104. | 6.104 ARGENTINA MARKET ANALYSIS BY DURATION OF USE
    105. | 6.105 ARGENTINA MARKET ANALYSIS BY AGE GROUP
    106. | 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    107. | 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL TYPE
    108. | 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    109. | 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY DURATION OF USE
    110. | 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP
    111. | 6.111 MEA MARKET ANALYSIS
    112. | 6.112 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    113. | 6.113 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL TYPE
    114. | 6.114 GCC COUNTRIES MARKET ANALYSIS BY END USER
    115. | 6.115 GCC COUNTRIES MARKET ANALYSIS BY DURATION OF USE
    116. | 6.116 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP
    117. | 6.117 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    118. | 6.118 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL TYPE
    119. | 6.119 SOUTH AFRICA MARKET ANALYSIS BY END USER
    120. | 6.120 SOUTH AFRICA MARKET ANALYSIS BY DURATION OF USE
    121. | 6.121 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP
    122. | 6.122 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    123. | 6.123 REST OF MEA MARKET ANALYSIS BY MATERIAL TYPE
    124. | 6.124 REST OF MEA MARKET ANALYSIS BY END USER
    125. | 6.125 REST OF MEA MARKET ANALYSIS BY DURATION OF USE
    126. | 6.126 REST OF MEA MARKET ANALYSIS BY AGE GROUP
    127. | 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. | 6.128 RESEARCH PROCESS OF MRFR
    129. | 6.129 DRO ANALYSIS OF HEALTHCARE
    130. | 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. | 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. | 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. | 6.133 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    134. | 6.134 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    135. | 6.135 HEALTHCARE, BY MATERIAL TYPE, 2024 (% SHARE)
    136. | 6.136 HEALTHCARE, BY MATERIAL TYPE, 2024 TO 2035 (USD Million)
    137. | 6.137 HEALTHCARE, BY END USER, 2024 (% SHARE)
    138. | 6.138 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
    139. | 6.139 HEALTHCARE, BY DURATION OF USE, 2024 (% SHARE)
    140. | 6.140 HEALTHCARE, BY DURATION OF USE, 2024 TO 2035 (USD Million)
    141. | 6.141 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE)
    142. | 6.142 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Million)
    143. | 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    5. | | 7.2.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    6. | | 7.2.3 BY END USER, 2026-2035 (USD Million)
    7. | | 7.2.4 BY DURATION OF USE, 2026-2035 (USD Million)
    8. | | 7.2.5 BY AGE GROUP, 2026-2035 (USD Million)
    9. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    10. | | 7.3.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    11. | | 7.3.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    12. | | 7.3.3 BY END USER, 2026-2035 (USD Million)
    13. | | 7.3.4 BY DURATION OF USE, 2026-2035 (USD Million)
    14. | | 7.3.5 BY AGE GROUP, 2026-2035 (USD Million)
    15. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    16. | | 7.4.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    17. | | 7.4.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    18. | | 7.4.3 BY END USER, 2026-2035 (USD Million)
    19. | | 7.4.4 BY DURATION OF USE, 2026-2035 (USD Million)
    20. | | 7.4.5 BY AGE GROUP, 2026-2035 (USD Million)
    21. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    22. | | 7.5.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    23. | | 7.5.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    24. | | 7.5.3 BY END USER, 2026-2035 (USD Million)
    25. | | 7.5.4 BY DURATION OF USE, 2026-2035 (USD Million)
    26. | | 7.5.5 BY AGE GROUP, 2026-2035 (USD Million)
    27. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    28. | | 7.6.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    29. | | 7.6.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    30. | | 7.6.3 BY END USER, 2026-2035 (USD Million)
    31. | | 7.6.4 BY DURATION OF USE, 2026-2035 (USD Million)
    32. | | 7.6.5 BY AGE GROUP, 2026-2035 (USD Million)
    33. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.7.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    35. | | 7.7.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    36. | | 7.7.3 BY END USER, 2026-2035 (USD Million)
    37. | | 7.7.4 BY DURATION OF USE, 2026-2035 (USD Million)
    38. | | 7.7.5 BY AGE GROUP, 2026-2035 (USD Million)
    39. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    40. | | 7.8.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    41. | | 7.8.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    42. | | 7.8.3 BY END USER, 2026-2035 (USD Million)
    43. | | 7.8.4 BY DURATION OF USE, 2026-2035 (USD Million)
    44. | | 7.8.5 BY AGE GROUP, 2026-2035 (USD Million)
    45. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    46. | | 7.9.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    47. | | 7.9.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    48. | | 7.9.3 BY END USER, 2026-2035 (USD Million)
    49. | | 7.9.4 BY DURATION OF USE, 2026-2035 (USD Million)
    50. | | 7.9.5 BY AGE GROUP, 2026-2035 (USD Million)
    51. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    52. | | 7.10.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    53. | | 7.10.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    54. | | 7.10.3 BY END USER, 2026-2035 (USD Million)
    55. | | 7.10.4 BY DURATION OF USE, 2026-2035 (USD Million)
    56. | | 7.10.5 BY AGE GROUP, 2026-2035 (USD Million)
    57. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    58. | | 7.11.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    59. | | 7.11.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    60. | | 7.11.3 BY END USER, 2026-2035 (USD Million)
    61. | | 7.11.4 BY DURATION OF USE, 2026-2035 (USD Million)
    62. | | 7.11.5 BY AGE GROUP, 2026-2035 (USD Million)
    63. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.12.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    65. | | 7.12.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    66. | | 7.12.3 BY END USER, 2026-2035 (USD Million)
    67. | | 7.12.4 BY DURATION OF USE, 2026-2035 (USD Million)
    68. | | 7.12.5 BY AGE GROUP, 2026-2035 (USD Million)
    69. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    70. | | 7.13.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    71. | | 7.13.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    72. | | 7.13.3 BY END USER, 2026-2035 (USD Million)
    73. | | 7.13.4 BY DURATION OF USE, 2026-2035 (USD Million)
    74. | | 7.13.5 BY AGE GROUP, 2026-2035 (USD Million)
    75. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    76. | | 7.14.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    77. | | 7.14.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    78. | | 7.14.3 BY END USER, 2026-2035 (USD Million)
    79. | | 7.14.4 BY DURATION OF USE, 2026-2035 (USD Million)
    80. | | 7.14.5 BY AGE GROUP, 2026-2035 (USD Million)
    81. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    82. | | 7.15.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    83. | | 7.15.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    84. | | 7.15.3 BY END USER, 2026-2035 (USD Million)
    85. | | 7.15.4 BY DURATION OF USE, 2026-2035 (USD Million)
    86. | | 7.15.5 BY AGE GROUP, 2026-2035 (USD Million)
    87. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    88. | | 7.16.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    89. | | 7.16.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    90. | | 7.16.3 BY END USER, 2026-2035 (USD Million)
    91. | | 7.16.4 BY DURATION OF USE, 2026-2035 (USD Million)
    92. | | 7.16.5 BY AGE GROUP, 2026-2035 (USD Million)
    93. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.17.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    95. | | 7.17.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    96. | | 7.17.3 BY END USER, 2026-2035 (USD Million)
    97. | | 7.17.4 BY DURATION OF USE, 2026-2035 (USD Million)
    98. | | 7.17.5 BY AGE GROUP, 2026-2035 (USD Million)
    99. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    100. | | 7.18.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    101. | | 7.18.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    102. | | 7.18.3 BY END USER, 2026-2035 (USD Million)
    103. | | 7.18.4 BY DURATION OF USE, 2026-2035 (USD Million)
    104. | | 7.18.5 BY AGE GROUP, 2026-2035 (USD Million)
    105. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    106. | | 7.19.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    107. | | 7.19.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    108. | | 7.19.3 BY END USER, 2026-2035 (USD Million)
    109. | | 7.19.4 BY DURATION OF USE, 2026-2035 (USD Million)
    110. | | 7.19.5 BY AGE GROUP, 2026-2035 (USD Million)
    111. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    112. | | 7.20.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    113. | | 7.20.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    114. | | 7.20.3 BY END USER, 2026-2035 (USD Million)
    115. | | 7.20.4 BY DURATION OF USE, 2026-2035 (USD Million)
    116. | | 7.20.5 BY AGE GROUP, 2026-2035 (USD Million)
    117. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    118. | | 7.21.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    119. | | 7.21.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    120. | | 7.21.3 BY END USER, 2026-2035 (USD Million)
    121. | | 7.21.4 BY DURATION OF USE, 2026-2035 (USD Million)
    122. | | 7.21.5 BY AGE GROUP, 2026-2035 (USD Million)
    123. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.22.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    125. | | 7.22.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    126. | | 7.22.3 BY END USER, 2026-2035 (USD Million)
    127. | | 7.22.4 BY DURATION OF USE, 2026-2035 (USD Million)
    128. | | 7.22.5 BY AGE GROUP, 2026-2035 (USD Million)
    129. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    130. | | 7.23.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    131. | | 7.23.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    132. | | 7.23.3 BY END USER, 2026-2035 (USD Million)
    133. | | 7.23.4 BY DURATION OF USE, 2026-2035 (USD Million)
    134. | | 7.23.5 BY AGE GROUP, 2026-2035 (USD Million)
    135. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    136. | | 7.24.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    137. | | 7.24.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    138. | | 7.24.3 BY END USER, 2026-2035 (USD Million)
    139. | | 7.24.4 BY DURATION OF USE, 2026-2035 (USD Million)
    140. | | 7.24.5 BY AGE GROUP, 2026-2035 (USD Million)
    141. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    142. | | 7.25.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    143. | | 7.25.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    144. | | 7.25.3 BY END USER, 2026-2035 (USD Million)
    145. | | 7.25.4 BY DURATION OF USE, 2026-2035 (USD Million)
    146. | | 7.25.5 BY AGE GROUP, 2026-2035 (USD Million)
    147. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    148. | | 7.26.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    149. | | 7.26.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    150. | | 7.26.3 BY END USER, 2026-2035 (USD Million)
    151. | | 7.26.4 BY DURATION OF USE, 2026-2035 (USD Million)
    152. | | 7.26.5 BY AGE GROUP, 2026-2035 (USD Million)
    153. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    154. | | 7.27.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    155. | | 7.27.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    156. | | 7.27.3 BY END USER, 2026-2035 (USD Million)
    157. | | 7.27.4 BY DURATION OF USE, 2026-2035 (USD Million)
    158. | | 7.27.5 BY AGE GROUP, 2026-2035 (USD Million)
    159. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    160. | | 7.28.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    161. | | 7.28.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    162. | | 7.28.3 BY END USER, 2026-2035 (USD Million)
    163. | | 7.28.4 BY DURATION OF USE, 2026-2035 (USD Million)
    164. | | 7.28.5 BY AGE GROUP, 2026-2035 (USD Million)
    165. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    166. | | 7.29.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    167. | | 7.29.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    168. | | 7.29.3 BY END USER, 2026-2035 (USD Million)
    169. | | 7.29.4 BY DURATION OF USE, 2026-2035 (USD Million)
    170. | | 7.29.5 BY AGE GROUP, 2026-2035 (USD Million)
    171. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    172. | | 7.30.1 BY PRODUCT TYPE, 2026-2035 (USD Million)
    173. | | 7.30.2 BY MATERIAL TYPE, 2026-2035 (USD Million)
    174. | | 7.30.3 BY END USER, 2026-2035 (USD Million)
    175. | | 7.30.4 BY DURATION OF USE, 2026-2035 (USD Million)
    176. | | 7.30.5 BY AGE GROUP, 2026-2035 (USD Million)
    177. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    178. | | 7.31.1
    179. | 7.32 ACQUISITION/PARTNERSHIP
    180. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Product Type (USD Million, 2022-2035)

  • Copper Intrauterine Device
  • Hormonal Intrauterine Device
  • Non-Hormonal Intrauterine Device

Healthcare By Material Type (USD Million, 2022-2035)

  • Plastic
  • Copper
  • Silicone
  • Steel

Healthcare By End User (USD Million, 2022-2035)

  • Hospitals
  • Clinics
  • Home Care

Healthcare By Duration of Use (USD Million, 2022-2035)

  • Short-term
  • Long-term

Healthcare By Age Group (USD Million, 2022-2035)

  • Adolescents
  • Adults
  • Women of Reproductive Age
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓